Glycomine Employee Directory

Glycomine corporate office is located in 733 Industrial Rd, San Carlos, California, 94070, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

Medical & Health

4

Engineering & Technical

3

C-Suite

2

Finance

1

Marketing

1

Legal

1

Glycomine CEO

SA
United States flag for contact location.
Steven AxonChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Glycomine

  • RM
    United States flag for contact location.
    Rose Marino

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Glycomine Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Glycomine

Hundreds of professionals searching for Glycomine have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Glycomine

Explore people who held key positions, contributed to Glycomine's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding Glycomine Employees

How many employees does Glycomine have?
Glycomine has 1-10 employees
Who is the CEO of Glycomine?
Glycomine’s CEO is Steven Axon
Who are Glycomine key employees?
Some of Glycomine key employees are Rose Marino
Where is Glycomine located?
Glycomine’s headquarters are located at 733 Industrial Rd, San Carlos, California, 94070, United States
How do I contact Glycomine?
Glycomine Contact Info: Phone number: (650) 264-7560 Website: www.glycomine.com
What does Glycomine do?

Glycomine Inc., founded in 2014, is a private biotechnology company headquartered in San Carlos, California. The company focuses on developing replacement therapies for serious rare genetic disorders, particularly those involving metabolism and protein misfolding. Its lead candidate, GLM101, is a mannose-1-phosphate replacement therapy in clinical... development for treating PMM2-CDG (CDG-1a), a congenital disorder of glycosylation. Glycomines approach combines substrates, enzymes, or proteins with targeted delivery systems to restore cellular function, aiming to address unmet medical needs in rare disease communities.Read More

Is Glycomine a public company?
Glycomine is private company therefore does not currently have an official ticker symbol
See more information about Glycomine Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.